Report overview
The global Long-Acting Injectable (LAI) Antipsychotic market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Aripiprazole Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Long-Acting Injectable (LAI) Antipsychotic include Alkermes, Eli Lilly and Company, Janssen Global Services, LLC, Abilify Maintena, Haldol, Otsuka Pharmaceutical, Aristada and Prolixin, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
This report aims to provide a comprehensive presentation of the global market for Long-Acting Injectable (LAI) Antipsychotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-Acting Injectable (LAI) Antipsychotic. This report contains market size and forecasts of Long-Acting Injectable (LAI) Antipsychotic in global, including the following market information:
Global Long-Acting Injectable (LAI) Antipsychotic Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Long-Acting Injectable (LAI) Antipsychotic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long-Acting Injectable (LAI) Antipsychotic Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Long-Acting Injectable (LAI) Antipsychotic Market Segment Percentages, by Type, 2023 (%)
Aripiprazole
Fluphenazine
Haloperidol
Others
Global Long-Acting Injectable (LAI) Antipsychotic Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Long-Acting Injectable (LAI) Antipsychotic Market Segment Percentages, by Application, 2023 (%)
Hospital
Retail Pharmacy
Others
Global Long-Acting Injectable (LAI) Antipsychotic Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Long-Acting Injectable (LAI) Antipsychotic Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Long-Acting Injectable (LAI) Antipsychotic revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Long-Acting Injectable (LAI) Antipsychotic revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC
Abilify Maintena
Haldol
Otsuka Pharmaceutical
Aristada
Prolixin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Long-Acting Injectable (LAI) Antipsychotic, market overview.
Chapter 2: Global Long-Acting Injectable (LAI) Antipsychotic market size in revenue.
Chapter 3: Detailed analysis of Long-Acting Injectable (LAI) Antipsychotic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Long-Acting Injectable (LAI) Antipsychotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
